Skip to content

Clinical study of low intensity focused ultrasound in promoting endometrial repair after abortion

Clinical study of low intensity focused ultrasound in promoting endometrial repair after abortion

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061152
Enrollment
Unknown
Registered
2022-06-15
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clinical study of low intensity focused ultrasound in promoting endometrial repair after abortion

Interventions

control group :The control group received no treatment
Drug group:In the drug group, subjects were treated with Euthyrene-drospirenone ethinylestradiol tablets, one tablet per day (3mg/0.02mg) after surgery, for 3 months.
Low intensity focused ultrasound intervention group:Intra-regional mobile therapy was carried out within 5cm of the symphysis pubis center at a speed of 1-2cm/s, with the intervention time of 15 minut
After 3 d
Electrical stimulation group:After surgery, the electrode was pasted on the uterine area, and the analgesic mode was adopted. The intervention lasted for 30 minutes, and the treatment lasted for 3 con

Sponsors

West China Second Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. Ultrasound examination showed intrauterine pregnancy, live fetus, anterior uterus, 6-10 weeks of gestation; 2. 18-35 years old, less than 3 times of qing Dynasty; 3. Menstrual regularity within 3 months before pregnancy; 4. Voluntarily give up pregnancy and accept induced abortion.

Exclusion criteria

Exclusion criteria: 1. intrauterine pregnancy, or preoperative use of progesterone fetal medicine; 2. abnormal ovarian and uterine structure, or suffering from fibroids, endometrial polyps, endometritis, etc.; 3. Patients with unstable vital signs and coagulation disorder; 4. Patients with serious liver, lung, kidney, cardiovascular and cerebrovascular diseases or diabetes and other endocrine diseases; 5. Patients with skin ulceration, infection or local sensory obstruction in the treatment area of the lower abdomen; 6. with mental illness, language and listening disorders, or unable to cooperate with doctors; 7. History of reproductive or other systemic malignancies; 8. heavy drinking habit and smoking history, progesterone taboo; 9. BMI > 28 Kg/M^2; 10. AIDS or diseases of the immune system; 11. With cardiac pacemaker.

Design outcomes

Primary

MeasureTime frame
1) Endometrial thickness examination [15] : Transvaginal ultrasonography was performed 3 weeks after surgery to evaluate the endometrial thickness of each group. 2) Hemodynamic indexes of endometrium: Transvaginal ultrasonography was performed 3 weeks after surgery to check the endometrial blood flow and subendometrial&#;

Secondary

MeasureTime frame
1) Endometrial type and volume: Transvaginal ultrasonography was performed 3 weeks after surgery to evaluate the endometrial type ABC in each group, analyze the proportion of each type in each group, and calculate the endometrial volume by THREE-DIMENSIONAL ultrasonography. 2) VAS pain score: pain score was&#;

Countries

China

Contacts

Public ContactXiaoli Wang
734126549@qq.com+86 13880911197

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026